| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | Jun 18, 2024 | APi Group Corp | 10% Owner | Sell | 15.0 | -1,951,782 | -100.00% | ✗ | $74.5M |
| Mar 5, 2024 | Mar 7, 2024 | APi Group Corp | 10% Owner | Sell | 15.0 | -3,038,617 | -60.89% | ✗ | $104.1M |
| Feb 28, 2024 | Mar 1, 2024 | APi Group Corp | 10% Owner | Sell | 15.0 | -4,065,039 | -44.89% | ✗ | $150M |
| Jan 2, 2024 | Jan 4, 2024 | APi Group Corp | 10% Owner | Sell | 15.0 | -6,500,000 | -18.90% | ✗ | $203.5M |
| Jun 22, 2023 | Jun 26, 2023 | Roivant Sciences Ltd. | 10% Owner | Sell | 15.0 | -13,000,000 | -14.73% | ✗ | $128.7M |
| Dec 14, 2020 | Dec 16, 2020 | Adaptive Biotechnologies Corp | 10% Owner | Sell | 15.0 | -1,000,000 | -3.23% | ✗ | $55.7M |
| Nov 11, 2020 | Nov 13, 2020 | Adaptive Biotechnologies Corp | 10% Owner | Sell | 15.0 | -2,500,000 | -7.46% | ✗ | $123.8M |
| Jan 28, 2020 | Jan 30, 2020 | Adaptive Biotechnologies Corp | 10% Owner | Sell | 15.0 | -4,912,899 | -12.79% | ✗ | $122.7M |
| Jul 1, 2019 | Jul 2, 2019 | Adaptive Biotechnologies Corp | 10% Owner | Buy | 100.0 | +250,000 | 17.54% | ✗ | $5M |
| Jun 27, 2019 | Jun 28, 2019 | BridgeBio Pharma, Inc. | 10% Owner | Buy | 100.0 | +4,705,900 | 21.47% | ✗ | $80M |